Tag: ivosidenib

1. Compared to placebo and azacytidine, the combination of ivosidenib and azacitidine demonstrated significant clinical benefit for IDH1-mutated acute myeloid ...

1. Event-free survival and median overall survival were significantly longer in the combination group 2. Febrile neutropenia and infections occurred ...

1. Patients receiving Ivosidenib had longer overall survival as compared to patients on placebo. 2. Quality of life measures favored ...